Eterna Therapeutics Appoints James Bristol, Ph.D., Pharmaceutical Research and Drug Discovery Veteran, to Board of Directors
Bristol is a seasoned biopharmaceutical executive who has excelled as a corporate partner, board member, and strategic and technical advisor within our industry,” said Matt Angel, Ph.D., Chief Executive Officer and President of Eterna.
- Bristol is a seasoned biopharmaceutical executive who has excelled as a corporate partner, board member, and strategic and technical advisor within our industry,” said Matt Angel, Ph.D., Chief Executive Officer and President of Eterna.
- Before that, he worked at Parke-Davis for 20 years, where he held positions of increasing responsibility in Chemistry and Drug Discovery and participated in collaboration oversight committees.
- Early in his career, Dr. Bristol was a Principal Scientist at Schering-Plough, leading the gastrointestinal research program.
- His drug discovery research has resulted in numerous publications, abstracts, and patents.